Chemomab Therapeutics Ltd. American Depositary Share
Symbol: CMMB (NASDAQ)
2.80
▼ (-7.80%) -0.236
Company Description:
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
Key Stats
- Today's Open: $3.03
- Today's High: $3.03
- Today's Low: $2.745
- Today's Volume: 140.52K
- Yesterday Close: $3.0324
- Yesterday High: $3.09
- Yesterday Low: $3.01
- Yesterday Volume: 23.45K
- Last Min Volume: 70
- Last Min High: $2.812
- Last Min Low: $2.796
- Last Min VWAP: $2.812
Company Profile
- Name: Chemomab Therapeutics Ltd. American Depositary Share
- Website: https://www.chemomab.com
- Listed Date: 2021-03-17
- Location: TEL AVIV, L3
- Market Status: Active
- CIK Number: 0001534248
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $15.74M
- Round Lot: 100
- Outstanding Shares: 5.19M
- Asset Type: ADRC
RECENT FILINGS FOR CMMB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-22 | 6-K | View |
| 2025-08-14 | 6-K | View |
| 2025-08-11 | SCHEDULE 13G/A | View |
| 2025-08-07 | SCHEDULE 13G/A | View |
| 2025-08-07 | SCHEDULE 13G | View |
| 2025-07-25 | 6-K | View |
| 2025-07-25 | 424B5 | View |
| 2025-07-01 | 6-K | View |
| 2025-06-23 | SCHEDULE 13D/A | View |
| 2025-05-27 | 6-K | View |
| 2025-05-15 | 6-K | View |
| 2025-04-15 | 6-K | View |
| 2025-04-10 | SCHEDULE 13G/A | View |
| 2025-04-04 | 20-F | View |
| 2025-03-27 | 6-K | View |
| 2025-03-20 | 6-K | View |
| 2025-03-03 | 6-K | View |
| 2025-02-19 | 6-K | View |
| 2024-12-10 | EFFECT | View |
| 2024-12-02 | POS AM | View |
Latest News on CMMB